Literature DB >> 26884338

Identification of an Extracellular Gate for the Proton-coupled Folate Transporter (PCFT-SLC46A1) by Cysteine Cross-linking.

Rongbao Zhao1, Mitra Najmi2, Andras Fiser3, I David Goldman4.   

Abstract

The proton-coupled folate transporter (PCFT, SLC46A1) is required for intestinal folate absorption and folate homeostasis in humans. A homology model of PCFT, based upon theEscherichia coliglycerol 3-phosphate transporter structure, predicted that PCFT transmembrane domains (TMDs) 1, 2, 7, and 11 form an extracellular gate in the inward-open conformation. To assess this model, five residues (Gln(45)-TMD1, Asn(90)-TMD2, Leu(290)-TMD7, Ser(407)-TMD11 and Asn(411)-TMD11) in the predicted gate were substituted with Cys to generate single and nine double mutants. Transport function of the mutants was assayed in transient transfectants by measurement of [(3)H]substrate influx as was accessibility of the Cys residues to biotinylation. Pairs of Cys residues were assessed for spontaneous formation of a disulfide bond, induction of a disulfide bond by oxidization with dichloro(1,10-phenanthroline)copper (II) (CuPh), or the formation of a Cd(2+)complex. The data were consistent with the formation of a spontaneous disulfide bond between the N90C/S407C pair and a CuPh- and Cd(2+)-induced disulfide bond and complex, respectively, for the Q45C/L290C and L290C/N411C pairs. The decrease in activity induced by cross-linkage of the Cys residue pairs was due to a decrease in the influxVmaxconsistent with restriction in the mobility of the transporter. The presence of folate substrate decreased the CuPh-induced inhibition of transport. Hence, the data support the glycerol 3-phosphate transporter-based homology model of PCFT and the presence of an extracellular gate formed by TMDs 1, 2, 7, and 11.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cysteine-mediated cross-linking; folate; homology modeling; membrane transport; transporter

Mesh:

Substances:

Year:  2016        PMID: 26884338      PMCID: PMC4825018          DOI: 10.1074/jbc.M115.693929

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Adjacent pore-lining residues within sodium channels identified by paired cysteine mutagenesis.

Authors:  J P Bénitah; G F Tomaselli; E Marban
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Recognition of errors in three-dimensional structures of proteins.

Authors:  M J Sippl
Journal:  Proteins       Date:  1993-12

3.  Membrane topological analysis of the proton-coupled folate transporter (PCFT-SLC46A1) by the substituted cysteine accessibility method.

Authors:  Rongbao Zhao; Ersin Selcuk Unal; Daniel Sanghoon Shin; I David Goldman
Journal:  Biochemistry       Date:  2010-04-06       Impact factor: 3.162

4.  The functional roles of the His247 and His281 residues in folate and proton translocation mediated by the human proton-coupled folate transporter SLC46A1.

Authors:  Ersin Selcuk Unal; Rongbao Zhao; Min-Hwang Chang; Andras Fiser; Michael F Romero; I David Goldman
Journal:  J Biol Chem       Date:  2009-04-23       Impact factor: 5.157

5.  Role of the glutamate 185 residue in proton translocation mediated by the proton-coupled folate transporter SLC46A1.

Authors:  Ersin Selcuk Unal; Rongbao Zhao; I David Goldman
Journal:  Am J Physiol Cell Physiol       Date:  2009-04-29       Impact factor: 4.249

6.  A prominent low-pH methotrexate transport activity in human solid tumors: contribution to the preservation of methotrexate pharmacologic activity in HeLa cells lacking the reduced folate carrier.

Authors:  Rongbao Zhao; Feng Gao; Marie Hanscom; I David Goldman
Journal:  Clin Cancer Res       Date:  2004-01-15       Impact factor: 12.531

7.  Selective preservation of pemetrexed pharmacological activity in HeLa cells lacking the reduced folate carrier: association with the presence of a secondary transport pathway.

Authors:  Rongbao Zhao; Marie Hanscom; Shrikanta Chattopadhyay; I David Goldman
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

8.  Hereditary folate malabsorption: a positively charged amino acid at position 113 of the proton-coupled folate transporter (PCFT/SLC46A1) is required for folic acid binding.

Authors:  Inbal Lasry; Bluma Berman; Fabian Glaser; Gerrit Jansen; Yehuda G Assaraf
Journal:  Biochem Biophys Res Commun       Date:  2009-06-07       Impact factor: 3.575

9.  A novel loss-of-function mutation in the proton-coupled folate transporter from a patient with hereditary folate malabsorption reveals that Arg 113 is crucial for function.

Authors:  Inbal Lasry; Bluma Berman; Rachel Straussberg; Yael Sofer; Hanna Bessler; Mohamad Sharkia; Fabian Glaser; Gerrit Jansen; Stavit Drori; Yehuda G Assaraf
Journal:  Blood       Date:  2008-06-17       Impact factor: 22.113

10.  N-linked glycosylation and its impact on the electrophoretic mobility and function of the human proton-coupled folate transporter (HsPCFT).

Authors:  Ersin Selcuk Unal; Rongbao Zhao; Andong Qiu; I David Goldman
Journal:  Biochim Biophys Acta       Date:  2008-03-20
View more
  12 in total

1.  Residues in the eighth transmembrane domain of the proton-coupled folate transporter (SLC46A1) play an important role in defining the aqueous translocation pathway and in folate substrate binding.

Authors:  Srinivas Aluri; Rongbao Zhao; Andras Fiser; I David Goldman
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-08-09       Impact factor: 3.747

Review 2.  The proton-coupled folate transporter (PCFT-SLC46A1) and the syndrome of systemic and cerebral folate deficiency of infancy: Hereditary folate malabsorption.

Authors:  Rongbao Zhao; Srinivas Aluri; I David Goldman
Journal:  Mol Aspects Med       Date:  2016-09-21

Review 3.  The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer.

Authors:  Larry H Matherly; Zhanjun Hou; Aleem Gangjee
Journal:  Cancer Chemother Pharmacol       Date:  2017-11-10       Impact factor: 3.333

4.  Substitutions that lock and unlock the proton-coupled folate transporter (PCFT-SLC46A1) in an inward-open conformation.

Authors:  Srinivas Aluri; Rongbao Zhao; Kai Lin; Daniel Sanghoon Shin; Andras Fiser; I David Goldman
Journal:  J Biol Chem       Date:  2019-03-11       Impact factor: 5.157

5.  Impact of posttranslational modifications of engineered cysteines on the substituted cysteine accessibility method: evidence for glutathionylation.

Authors:  Rongbao Zhao; Mitra Najmi; Srinivas Aluri; I David Goldman
Journal:  Am J Physiol Cell Physiol       Date:  2017-01-25       Impact factor: 4.249

6.  Substituted-cysteine accessibility and cross-linking identify an exofacial cleft in the 7th and 8th helices of the proton-coupled folate transporter (SLC46A1).

Authors:  Srinivas Aluri; Rongbao Zhao; Andras Fiser; I David Goldman
Journal:  Am J Physiol Cell Physiol       Date:  2017-11-22       Impact factor: 4.249

7.  Role of the tryptophan residues in proton-coupled folate transporter (PCFT-SLC46A1) function.

Authors:  Mitra Najmi; Rongbao Zhao; Andras Fiser; I David Goldman
Journal:  Am J Physiol Cell Physiol       Date:  2016-06-01       Impact factor: 4.249

8.  A proton-coupled folate transporter mutation causing hereditary folate malabsorption locks the protein in an inward-open conformation.

Authors:  He-Qin Zhan; Mitra Najmi; Kai Lin; Srinivas Aluri; Andras Fiser; I David Goldman; Rongbao Zhao
Journal:  J Biol Chem       Date:  2020-09-06       Impact factor: 5.157

9.  Hereditary folate malabsorption due to a mutation in the external gate of the proton-coupled folate transporter SLC46A1.

Authors:  Srinivas Aluri; Rongbao Zhao; Charlotte Lubout; Susanna M I Goorden; Andras Fiser; I David Goldman
Journal:  Blood Adv       Date:  2018-01-05

10.  Identification of the amino acid residue responsible for the myricetin sensitivity of human proton-coupled folate transporter.

Authors:  Takahiro Yamashiro; Tomoya Yasujima; Kinya Ohta; Katsuhisa Inoue; Hiroaki Yuasa
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.